The U.S. government is providing some relief to its own citizens in the wake of a pandemic.
The White House on Tuesday announced it has lifted a temporary ban on importing any pharmaceutical products containing anthrax-resistant coronaviruses, including some medications for the treatment of severe acute respiratory infections.
The move is part of President Donald Trump’s broader effort to reduce exposure to the deadly pathogens, which began in early March.
In a statement, the White House said the administration will suspend importation of all imported coronaviral drugs on Monday.
The president is expected to announce a similar move in the coming days.
The administration said it has also made available $1.5 billion to help countries that have been hit hard by the pandemic through public health campaigns, disaster relief, and public health-related programs.
The move comes amid a nationwide pandemic that has caused the deaths of more than 11,000 Americans and has led to the spread of many of the most deadly coronavireptases, including COVID-19, as well as dozens of new coronavviruses.
The White House announced earlier this month it will spend up to $10 billion to combat the virus, while other countries have pledged more than $200 billion.
President Donald Trump is expected on Monday to announce the creation of a new global partnership to combat coronavirosts.
The announcement is expected at a White House news conference, according to the WhiteHouse.gov website.